Serum Institute inks licensing agreement with Aridis Pharma

India |  News | 0 Comment | 01 Oct, 2019

US based Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel ant...Read more

Glenmark receives approval from Russia to market Montlezir

India |  News | 0 Comment | 30 Sep, 2019

Glenmark Pharmaceuticals has announced the approval from the Ministry of Healthcare, Russia to market Montlezir (Levocet...Read more

Biocon announces price reduction for insulin

India |  News | 0 Comment | 27 Sep, 2019

Kiran Mazumdar-Shaw, CMD, Biocon has promised to enable universal access to rh-Insulin by reducing prices to less than 1...Read more

Naidu foresees India as wellness capital of the world

India |  News | 0 Comment | 25 Sep, 2019

The Vice President of India, M. Venkaiah Naidu has called for making India a thriving hub for natural healing and wellne...Read more

3M signs MoU to launch “INFUZE”- a program in Infusion therapy

India |  News | 0 Comment | 24 Sep, 2019

3M India, a subsidiary of leading global innovation company has signed a MoU with Infusion Nurses Society (INS-Ind)...Read more

Biocon Biologics expands R&D footprint

India |  News | 0 Comment | 24 Sep, 2019

Asia’s premier biopharmaceuticals company, has announced that its subsidiary, Biocon Biologics, has acquired R&...Read more

Strides approves incremental investments in Stelis

India |  News | 0 Comment | 23 Sep, 2019

Strides Pharma Science Limited,a global pharmaceutical company headquartered in Bangalore, India, has announced that the...Read more

Eisai, Mylan to promote anti-cancer drug brands in India

India |  News | 0 Comment | 23 Sep, 2019

Eisai Co., Ltd. has announced that Eisai’s subsidiary Eisai Pharmaceuticals India Pvt. Ltd. and Mylan N. V. subsid...Read more

Glenmark receives Orphan Drug Designation for GBR 1342

India |  News | 0 Comment | 17 Sep, 2019

Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody can...Read more

AI can help scale up healthcare delivery in India: Ashutosh Lawania

India |  Opinion | 0 Comment | 16 Sep, 2019

Can you throw some light on your recent expansion in Delhi-NCR? mfine is an AI powered, on-demand healthcare platform ...Read more

Israel's Zebra inks pact with India's Medsynaptic

India |  News | 0 Comment | 16 Sep, 2019

Zebra Medical Vision, the deep learning medical imaging analytics company, has announced its partnership with Medsy...Read more

Biocon collaborates with China Medical System

India |  News | 0 Comment | 12 Sep, 2019

Biocon Ltd, Asia’s premier biopharmaceuticals company, has announced that it has signed a License and Supply Agree...Read more

3M supports Nobel Prize Series Event in India

India |  News | 0 Comment | 12 Sep, 2019

Nobel laureates and world-leading experts will meet in Delhi and Punjab India, to address the topic of “Teaching a...Read more

Sanofi India to sell Ankleshwar site to Zentiva

India |  News | 0 Comment | 11 Sep, 2019

The Board of Directors of Sanofi India Limited (SIL) has approved a transaction for the slump sale and transfe...Read more

Lupin receives USFDA approval for Ethacrynic Acid Tablets USP

India |  News | 0 Comment | 10 Sep, 2019

Indian Pharma major Lupin Limited (Lupin) on 9 Sep 2019, announced that it has received approval for its Ethacrynic Acid...Read more

Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound

India |  News | 0 Comment | 09 Sep, 2019

Boehringer Ingelheim and Lupin Limited (Lupin) has announced a licensing, development and commercialization agreement fo...Read more

GVK BIO announces new appointment

India |  News | 0 Comment | 05 Sep, 2019

GVK BIO, a leading global Contract Research and Development Organisation (CRDO), has announced the promotion of Sudhir K...Read more

Biocon receives USFDA’s Complete Response Letter for insulin glargine

India |  News | 0 Comment | 03 Sep, 2019

Biocon said that the US Food and Drug Administration (US FDA) has issued a complete response letter (CRL) for the New Dr...Read more